HAYES CHRISTOPHER G. (General Counsel) sold 25.2% of their position (35.71K shares) of VERRICA PHARMACEUTICALS INC. on the open market
Open‑market sale worth $93.1K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/28/2024ACC: 0001415889-24-022427
Officer· General Counsel
Since Feb 2020
-35.71K
Net shares
Net seller
$93.1K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
35.71K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−26.18K
Price / share
$2.66
Trade value
$69.65K
% of position
18.5%
8/26/2024
141.49K→115.30K
Common Stock
Direct
Shares
−9.53K
Price / share
$2.46
Trade value
$23.44K
% of position
8.3%
8/27/2024
115.30K→105.77K
Total
Net shares
−35.71K
Net value
-$93.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/26/2024 | S · Sale | −26.18K | $2.66 | $69.65K | 18.5% | 141.49K | 115.30K |
| Common Stock Direct | 8/27/2024 | S · Sale | −9.53K | $2.46 | $23.44K | 8.3% | 115.30K | 105.77K |
| Total | −35.71K | -$93.09K | ||||||
Derivative Transactions0
No derivative transactions reported